| Dissecting the crosstalk between Nrf2 and NF-κB response pathways in drug-induced toxicity W Gao, L Guo, Y Yang, Y Wang, S Xia, H Gong, BK Zhang, M Yan Frontiers in cell and developmental biology 9, 809952, 2022 | 166 | 2022 |
| Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database S Xia, H Gong, Y Zhao, L Guo, Y Wang, R Ma, B Zhang, M Sarangdhar, ... Clinical Pharmacology & Therapeutics 114 (1), 211-219, 2023 | 17 | 2023 |
| Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality analysis based on … S Xia, H Gong, Y Wang, L Liu, Y Zhao, L Guo, B Zhang, M Sarangdhar, ... Frontiers in pharmacology 14, 1129730, 2023 | 12 | 2023 |
| Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study S Xia, YC Zhao, L Guo, H Gong, YK Wang, R Ma, BK Zhang, Y Sheng, ... Frontiers in Pharmacology 13, 967017, 2022 | 10 | 2022 |
| Strategies to improve the therapeutic efficacy of mesenchymal stem cell‐derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease L Zheng, H Gong, J Zhang, L Guo, Z Zhai, S Xia, Z Hu, J Chang, Y Jiang, ... Frontiers in Bioengineering and Biotechnology 11, 1322514, 2023 | 6 | 2023 |
| Association of pulmonary sepsis and immune checkpoint inhibitors: A pharmacovigilance study S Xia, H Gong, Y Zhao, L Guo, Y Wang, B Zhang, M Sarangdhar, ... Cancers 15 (1), 240, 2022 | 6 | 2022 |
| The pharmacology and mechanisms of traditional Chinese medicine in promoting liver regeneration: a new therapeutic option JT Ma, S Xia, BK Zhang, F Luo, L Guo, Y Yang, H Gong, M Yan Phytomedicine 116, 154893, 2023 | 5 | 2023 |
| Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System S Xia, J Ma, E Raschi, R Ma, B Zhang, L Guo, Y Noguchi, M Sarangdhar, ... Clinical Drug Investigation 43 (10), 773-783, 2023 | 4 | 2023 |
| Sunitinib induced hepatotoxicity in L02 cells via ROS-MAPKs signaling pathway TL Tang, Y Yang, L Guo, S Xia, B Zhang, M Yan Frontiers in Pharmacology 13, 1002142, 2022 | 4 | 2022 |
| Bioinformatics and network pharmacology analysis of DWYG capsule for improving liver regeneration: identification of active compounds and mechanisms C Zhang, S Xia, M Yan, F Luo, B Zhang, W Zou, H Gong Natural Product Research 38 (19), 3329-3335, 2024 | 1 | 2024 |
| The involvement of the Stat1/Nrf2 pathway in exacerbating Crizotinib-induced liver injury: implications for ferroptosis L Guo, JT Ma, MX Xiao, JY Liu, ZY Hu, S Xia, N Li, Y Yang, H Gong, Y Xi, ... Cell Death & Disease 15 (8), 600, 2024 | 1 | 2024 |
| Research progress on regulation of mitochondrial function by traditional Chinese medicine in alleviating acetaminophen-induced liver injury S Xia, R Cao, Z Hu, J Liu, X Fan, Z Jiang, H Gong, M Yan Precision Medication 1 (1), 100008, 2024 | | 2024 |
| Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database S Xia, JW Xu, KX Yan, Y Noguchi, M Sarangdhar, M Yan Frontiers in Pharmacology 15, 1413154, 2024 | | 2024 |
| Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in … S Xia, YF Li, E Raschi, BK Zhang, Y Noguchi, M Sarangdhar, M Yan, ... Frontiers in Pharmacology 15, 1275814, 2024 | | 2024 |
| Letter to the editor regarding" Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large-scale pharmacovigilance analysis" S Xia, H Gong, M Yan International immunopharmacology 115, 109705, 2023 | | 2023 |
| Mechanism of Glycyrrhizic Acid in Promoting Liver Regeneration by Activating the Β-Catenin Signaling Pathway R Cao, H Gong, S Xia, Z Hu, X Fan, B Zhai, L Guo, C Xia, Z Jiang, M Yan Available at SSRN 5023232, 0 | | |
